Skip to main content
Top
Published in: Medical Microbiology and Immunology 3/2013

01-06-2013 | Original Investigation

Involvement of (IgG and IgM)-secreting B lymphocytes in severity of autoimmune hepatitis type 1

Author: Ayaid Khadem Zgair

Published in: Medical Microbiology and Immunology | Issue 3/2013

Login to get access

Abstract

Autoimmune hepatitis type 1 (AIH1) is an autoimmune disease attacks the liver and characterized by periportal inflammation, elevated immunoglobulins, and autoantibodies. The central role of B lymphocyte in pathogenicity of AIH1 is unclear. Here, the effect of antibody-secreting cells activity in terms of number of plaque-forming cells (PFC) on severity of AIH1 was evaluated. The high number of PFC-(IgG and IgM) in peripheral blood of patients with AIH1 was observed and this was concomitant with increase in the number of CD4+ T lymphocyte, immunoglobulin (Ig) (IgG and IgM) concentrations, and levels of liver function tests (LFTs). However, the negative correlation (r < −0.5, P < 0.05) between the numbers of PFC-(IgG and IgM) and CD8+ T lymphocytes was reported here. The present study showed the positive relationship between the concentrations of Ig (IgG and IgM) and levels of LFTs (r > +0.5, P < 0.05). The high expression of IL-10 mRNA was found in the tissue culture of peripheral blood lymphocytes obtained from patients with AIH1 as compared with that isolated from control group (P < 0.05). The current study proved the direct role of (IgG and IgM)-secreting cells in severity of AIH1. This was associated with CD4+ cell numbers and IL-10 mRNA expression, and mediated by IgG and IgM.
Literature
1.
go back to reference Krawitt EL (1994) Autoimmune hepatitis: classification, heterogeneity, and treatment. Am J Med 96:S23–S26CrossRef Krawitt EL (1994) Autoimmune hepatitis: classification, heterogeneity, and treatment. Am J Med 96:S23–S26CrossRef
2.
go back to reference Meyer zum Buschenfelde KH, Lohse AW, Manns M, Poralla T (1990) Autoimmunity and liver disease. Hepatology 12:354–363PubMedCrossRef Meyer zum Buschenfelde KH, Lohse AW, Manns M, Poralla T (1990) Autoimmunity and liver disease. Hepatology 12:354–363PubMedCrossRef
3.
go back to reference Cohen IR, Wekerle H (1972) Autosensitisation of lymphocytes against thymus reticulum cells. Science 176:1324–1325PubMedCrossRef Cohen IR, Wekerle H (1972) Autosensitisation of lymphocytes against thymus reticulum cells. Science 176:1324–1325PubMedCrossRef
4.
go back to reference Pathmakanthan S, Kay EW, Murray FE (1998) Autoimmune chronic active hepatitis associated with the presence of antiphospholipid antibodies. Eur J Gastroenterol Hepatol 10:155–157PubMedCrossRef Pathmakanthan S, Kay EW, Murray FE (1998) Autoimmune chronic active hepatitis associated with the presence of antiphospholipid antibodies. Eur J Gastroenterol Hepatol 10:155–157PubMedCrossRef
5.
go back to reference Czaja AJ (2010) Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci 55:2144–2161PubMedCrossRef Czaja AJ (2010) Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci 55:2144–2161PubMedCrossRef
6.
go back to reference Makol A, Watt KD, Chowdhary VR (2011) Autoimmune hepatitis: a review of current diagnosis and treatment. Hepat Res Treat 390916 (epub 2011) Makol A, Watt KD, Chowdhary VR (2011) Autoimmune hepatitis: a review of current diagnosis and treatment. Hepat Res Treat 390916 (epub 2011)
9.
go back to reference Jerne NK, Nordin AA (1963) Cell-bound antibodies. In: Amor B, Koprowski H (eds) Science. Wistar Institute Press, Philadelphia, vol 140, p 405 Jerne NK, Nordin AA (1963) Cell-bound antibodies. In: Amor B, Koprowski H (eds) Science. Wistar Institute Press, Philadelphia, vol 140, p 405
10.
go back to reference Cunningham AJ, Szenberg A (1968) Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology 14:599–600PubMed Cunningham AJ, Szenberg A (1968) Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology 14:599–600PubMed
11.
go back to reference Keil DE, McGuinn WD, Dudley AC, EuDaly JG, Gilkeson GS, Peden-Adams MM (2009) N,N,-Diethyl-m-Toluamide (DEET) suppresses humoral immunological function in B6C3F1 mice. Toxicol Sci 108:110–123PubMedCrossRef Keil DE, McGuinn WD, Dudley AC, EuDaly JG, Gilkeson GS, Peden-Adams MM (2009) N,N,-Diethyl-m-Toluamide (DEET) suppresses humoral immunological function in B6C3F1 mice. Toxicol Sci 108:110–123PubMedCrossRef
12.
go back to reference Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169–176PubMedCrossRef Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169–176PubMedCrossRef
13.
go back to reference Pyrkov LM, Sokolova TA, Kopyakova LG, Rozen IS (1986) Microassay of total serum bilirubin on the ABFTs-1 bilirubin analyzer. Biomed Eng 20:156–157CrossRef Pyrkov LM, Sokolova TA, Kopyakova LG, Rozen IS (1986) Microassay of total serum bilirubin on the ABFTs-1 bilirubin analyzer. Biomed Eng 20:156–157CrossRef
14.
15.
go back to reference Henry RJ, Chiamori N, Golub OJ, Berkman S (1960) Revised spectrophotometric methods for the determination of glutamic oxalacetic transaminase, glutamic pyruvic transaminase and lactic acid dehydrogenase. Am J Clin Pathol 34:381–398PubMed Henry RJ, Chiamori N, Golub OJ, Berkman S (1960) Revised spectrophotometric methods for the determination of glutamic oxalacetic transaminase, glutamic pyruvic transaminase and lactic acid dehydrogenase. Am J Clin Pathol 34:381–398PubMed
16.
go back to reference Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21:77–89CrossRef Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21:77–89CrossRef
17.
go back to reference Zgair AK (2012) The effect of high temperature on the kinetics of lipopolysaccharide (LPS)-induced human monocytes activity in vitro. Cell Immunol 275:55–60PubMedCrossRef Zgair AK (2012) The effect of high temperature on the kinetics of lipopolysaccharide (LPS)-induced human monocytes activity in vitro. Cell Immunol 275:55–60PubMedCrossRef
19.
go back to reference Golstein P, Gomperts BD (1975) Non-T cell-mediated cytolysis of antibody-coated sheep red blood cells requires Mg++ but not Ca++: an argument against a conventional “stimulus-secretion” mechanism for cytolysis. J Immunol 114:1264–1268PubMed Golstein P, Gomperts BD (1975) Non-T cell-mediated cytolysis of antibody-coated sheep red blood cells requires Mg++ but not Ca++: an argument against a conventional “stimulus-secretion” mechanism for cytolysis. J Immunol 114:1264–1268PubMed
21.
22.
go back to reference Bujalska IJ, Durrani OM, Abbott J, Onyimba CU, Khosla P, Moosavi AH, Reuser TTQ, Stewart PM, Tomlinson JW, Walker EA, Rauz S (2007) Characterisation of 11b-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat. J Endocrinol 192:279–288PubMedCrossRef Bujalska IJ, Durrani OM, Abbott J, Onyimba CU, Khosla P, Moosavi AH, Reuser TTQ, Stewart PM, Tomlinson JW, Walker EA, Rauz S (2007) Characterisation of 11b-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat. J Endocrinol 192:279–288PubMedCrossRef
23.
go back to reference Garcia-Rodriguez S, Callejas-Rubio J-L, Ortego-Centeno N, Zumaquero E, Ríos-Fernandez R, Arias-Santiago S, Navarro P, Sancho J, Zubiaur M (2012) Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patients. Mediators Inflamm Article ID 495934, 14 pp. doi:10.1155/2012/495934 Garcia-Rodriguez S, Callejas-Rubio J-L, Ortego-Centeno N, Zumaquero E, Ríos-Fernandez R, Arias-Santiago S, Navarro P, Sancho J, Zubiaur M (2012) Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patients. Mediators Inflamm Article ID 495934, 14 pp. doi:10.​1155/​2012/​495934
24.
25.
go back to reference Agarwal K, Czaja AJ, Jones DEJ, Donaldson PT (2000) Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 31:49–53PubMedCrossRef Agarwal K, Czaja AJ, Jones DEJ, Donaldson PT (2000) Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 31:49–53PubMedCrossRef
26.
go back to reference Vergani D, Mieli-Vergani G, Mondelli M, Portmann B, Eddleston AL (1987) Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cellmediated cytotoxicity and liver damage. Liver 7:307–315PubMed Vergani D, Mieli-Vergani G, Mondelli M, Portmann B, Eddleston AL (1987) Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cellmediated cytotoxicity and liver damage. Liver 7:307–315PubMed
27.
go back to reference Longhi MS, Ma Y, Mieli-Vergani G, Vergani D (2010) Aetiopathogenesis of autoimmune hepatitis. J Autoimmun 34:7–14PubMedCrossRef Longhi MS, Ma Y, Mieli-Vergani G, Vergani D (2010) Aetiopathogenesis of autoimmune hepatitis. J Autoimmun 34:7–14PubMedCrossRef
28.
go back to reference Fujii Y, Kawamura H, Kawamura T, Kanda Y, Matsumoto H, Kobayashi T, Yamamoto T, Aoyama T, Abo T (2010) Co-appearance of autoantibody-producing B220(low) B cells with NKT cells in the course of hepatic injury. Cell Immunol 260:105–112PubMedCrossRef Fujii Y, Kawamura H, Kawamura T, Kanda Y, Matsumoto H, Kobayashi T, Yamamoto T, Aoyama T, Abo T (2010) Co-appearance of autoantibody-producing B220(low) B cells with NKT cells in the course of hepatic injury. Cell Immunol 260:105–112PubMedCrossRef
29.
go back to reference Li R, Rosendahl A, Brodin G, Cheng AM, Ahgren A, Sundquist C, Kulkarni S, Pawson T, Heldin CH, Heuchel RL (2006) Deletion of exon I of SMAD7 in mice results in altered B cell responses. J Immunol 176:6777–6784PubMed Li R, Rosendahl A, Brodin G, Cheng AM, Ahgren A, Sundquist C, Kulkarni S, Pawson T, Heldin CH, Heuchel RL (2006) Deletion of exon I of SMAD7 in mice results in altered B cell responses. J Immunol 176:6777–6784PubMed
30.
go back to reference Brandão DF, Ramalho FS, Martinelli AL, Zucoloto S, Ramalho LN (2010) Relationship between plasma cells and hepatic stellate cells in autoimmune hepatitis. Pathol Res Pract 206:800–804PubMedCrossRef Brandão DF, Ramalho FS, Martinelli AL, Zucoloto S, Ramalho LN (2010) Relationship between plasma cells and hepatic stellate cells in autoimmune hepatitis. Pathol Res Pract 206:800–804PubMedCrossRef
31.
go back to reference Cabibi D, Tarantino G, Barbaria F, Campione M, Craxì A, Di Marco V (2010) Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. Dig Liver Dis 42:585–592PubMedCrossRef Cabibi D, Tarantino G, Barbaria F, Campione M, Craxì A, Di Marco V (2010) Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. Dig Liver Dis 42:585–592PubMedCrossRef
32.
go back to reference Barcellini W, Zanella A (2011) Rituximab therapy for autoimmune haematological diseases. Eur J Int Med 22:220–229CrossRef Barcellini W, Zanella A (2011) Rituximab therapy for autoimmune haematological diseases. Eur J Int Med 22:220–229CrossRef
33.
go back to reference Stasi R (2010) Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Semin Hematol 47:170–179PubMedCrossRef Stasi R (2010) Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Semin Hematol 47:170–179PubMedCrossRef
Metadata
Title
Involvement of (IgG and IgM)-secreting B lymphocytes in severity of autoimmune hepatitis type 1
Author
Ayaid Khadem Zgair
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 3/2013
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-012-0287-5

Other articles of this Issue 3/2013

Medical Microbiology and Immunology 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.